Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v23-EN Version v13-EN
Language English English
Date Updated 2024-04-30 2024-02-26
Drug Identification Number 02405156 02405156
Brand name AURO-SIMVASTATIN AURO-SIMVASTATIN
Common or Proper name AURO-SIMVASTATIN AURO-SIMVASTATIN
Company Name AURO PHARMA INC AURO PHARMA INC
Ingredients SIMVASTATIN SIMVASTATIN
Strength(s) 10MG 10MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 100's nad 500's 100's nad 500's
ATC code C10AA C10AA
ATC description LIPID MODIFYING AGENTS, PLAIN LIPID MODIFYING AGENTS, PLAIN
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date 2023-10-31 2023-10-31
Actual start date 2023-11-01
Estimated end date 2024-05-01 2024-04-15
Actual end date 2024-04-29
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments